Clinical trial
The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in…
NCT00437918 · Inje University, Other · Completed
Key facts
| NCT number | NCT00437918 |
|---|---|
| Title | The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic Patients |
| Official title | Phase IV Study on Predictive Markers for the Effectiveness of Nateglinide or Acarbose for Controlling Post-Prandial Glucose in Type 2 Diabetics Already on Optimized Insulin Glargine Therapy |
| Lead sponsor | Inje University, Other |
| Collaborators | Sanofi Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | nateglinide, acarbose |
| Enrollment | 85 |
| Start date | Jan 1, 2007 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Feb 21, 2007 |
| Last update posted | Mar 24, 2008 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: